Michael D. Geschwind MD PhD, FAAN, FANA
Professor of neurology and holds the Michael J. Homer Chair in Neurology in the UCSF School of Medicine
Join to View Full Profile
1651 4th Street, Suite 212San Francisco, CA 94158
Phone+1 415-353-2057
Fax+1 415-353-8292
Dr. Geschwind is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Geschwind is a neurologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center. He received his medical degree from Albert Einstein College of Medicine and has been in practice 20 years. He is experienced in prion diseases, spinocerebellar ataxia, dementia, autoimmune neurology, and huntington's disesae.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1997 - 2000
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1996 - 1997
Albert Einstein College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2000 - 2026
FL State Medical License 2016 - 2018
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
- TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease Start of enrollment: 2005 Sep 01
- CJD (Creutzfeldt-Jakob Disease) Quinacrine Study Start of enrollment: 2005 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease.Jennifer Zitser, Sven Forner, Katherine Wong, Jin Chengshi, John Neuhaus
Brain. 2025-03-28 - Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia.Anna L Burt, Gilbert L'Italien, Susan L Perlman, Liana S Rosenthal, Sheng-Han Kuo
Movement Disorders. 2025-03-04 - "By the Time We Knew …": Poetic Analysis of End-of-Life Caregiving Experiences for Rapidly Progressive and Slower-Duration Dementia Syndromes.Krista L Harrison, Brianna E Morgan, Juliana Friend, Sarah B Garrett, David Looi
Journal of the American Geriatrics Society. 2025-02-05
Journal Articles
- Neuroimaging in DementiaMichael D Geschwind, Fanny M Elahi, Christopher P Hess, Seminars in Neurology
Press Mentions
146th Annual Meeting of the American Neurological Association to Focus on Research and Development of Neurologic Disease TherapeuticsOctober 5th, 2021
Police Have Investigated Five Cases in Five Years of Dementia Sufferers Causing Fatal Injuries to OthersMay 24th, 2019
The Eyes Have ItNovember 20th, 2018- Join now to see all
Grant Support
- Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular diseaseUNIVERSITY OF WISCONSIN-MADISON2021–2025
- Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025
- Predicting progression of human prion diseaseNIA2013–2018
- Early Diagnosis Of Human Prion DiseaseNational Institute On Aging2008–2011
- New Clinical Approaches To Creutzfeldt-Jakob DiseaseNational Institute On Aging2003–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
